Researcher.Life Logo

Hepatobiliary and Pancreatic Diseases International : Impact Factor & More

eISSN: 2352-9377pISSN: 1499-3872

Key Metrics

CiteScore
5.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Hepatology
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatobiliary and Pancreatic Diseases International

Hepatobiliary and Pancreatic Diseases International Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Hepatobiliary and Pancreatic Diseases International ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatobiliary and Pancreatic Diseases International

Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma: Recent developments and insights.
  • 11 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment.
  • 11 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Ex vivo liver resection and autotransplantation for hepatic alveolar echinococcosis with cavernous transformation of the portal vein.
  • 4 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Predictive factors of postoperative ascites after laparoscopic pancreaticoduodenectomy for periampullary carcinoma.
  • 1 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Utilizing inferior right hepatic vein as a landmark for laparoscopic anatomic segment 7 liver resection (with video).
  • 1 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Thanks
  • 1 Dec 2025
  • Hepatobiliary &amp; Pancreatic Diseases International
Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma: Recent developments and insights.
  • 11 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment.
  • 11 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Ex vivo liver resection and autotransplantation for hepatic alveolar echinococcosis with cavernous transformation of the portal vein.
  • 4 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Predictive factors of postoperative ascites after laparoscopic pancreaticoduodenectomy for periampullary carcinoma.
  • 1 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Utilizing inferior right hepatic vein as a landmark for laparoscopic anatomic segment 7 liver resection (with video).
  • 1 Dec 2025
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Thanks
  • 1 Dec 2025
  • Hepatobiliary &amp; Pancreatic Diseases International

FAQs on Hepatobiliary and Pancreatic Diseases International